Tag Archives: NSF
Nephrogenic Systemic Fibrosis and the FDA’s Warnings
Written by Neil Kurtzman | 1st October 2010There is an article (Change in Use of Gadolinium-Enhanced Magnetic Resonance Studies in Kidney Disease Patients After US Food and Drug Administration Warnings: A Cross-sectional Study of Veterans Affairs Health Care System Data From 2005-2008 ) and an editorial (Nephrogenic Systemic Fibrosis and Gadolinium-Enhanced Magnetic Resonance Imaging: Does a US Food and Drug Administration Alert…
› Read the full entry
